FREMONT, CA, United States of America

Jia-ning Xiang

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 4.7

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jia-ning Xiang

Introduction

Jia-ning Xiang is a prominent inventor based in Fremont, California. He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work focuses on developing innovative pharmaceutical compositions and dosage forms that enhance the efficacy of various compounds.

Latest Patents

Among his latest patents, Jia-ning Xiang has developed pharmaceutical compositions and oral dosage forms of ketamine derivatives. These compositions are designed to exhibit a zero-order release profile, ensuring a consistent release of the active ingredient. Additionally, he has created modified release compositions of a gamma-hydroxybutyric acid derivative. These pharmaceutical granulations feature a functional coating that allows for either immediate or modified release of the active compound, 4-((L-valyl)oxy)butanoic acid, making them suitable for oral pharmaceutical applications.

Career Highlights

Jia-ning Xiang's career is marked by his dedication to advancing pharmaceutical science. His innovative approaches to drug formulation have positioned him as a key figure in the industry. He is currently associated with XWPharma Ltd., where he continues to push the boundaries of pharmaceutical research and development.

Collaborations

Throughout his career, Jia-ning Xiang has collaborated with notable professionals in the field, including Daniel M. Canafax and William W. Xiang. These collaborations have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Jia-ning Xiang's contributions to pharmaceutical innovations are noteworthy and impactful. His patents reflect a commitment to improving drug delivery systems and enhancing patient outcomes. His work continues to inspire advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…